Progress in understanding the pathogenesis of BPD using the baboon and sheep models

Seminars in Perinatology

Volumn 37, Issue 2, 2013, Pages 60-68

  Albertine, Kurt H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Airway expiratory resistance; Alveolar formation; Alveolar simplification; Endothelial nitric oxide synthase; Epigenetics; Nasal CPAP; Neonatal chronic lung disease; Nitric oxide; Pulmonary hypertension; Vitamin A

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; SOMATOMEDIN C;

AIRWAY RESISTANCE; BABOON; CHRONIC LUNG DISEASE; DISEASE MODEL; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; EXPIRATORY FLOW; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; LAMB; LUNG DIFFUSION CAPACITY; LUNG DYSPLASIA; LUNG GAS EXCHANGE; MOLECULAR PATHOLOGY; NONHUMAN; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SOMATOMEDIN C GENE;

AIRWAY RESISTANCE; ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; NONINVASIVE VENTILATION; PAPIO; PULMONARY GAS EXCHANGE; RESPIRATION, ARTIFICIAL; SHEEP;

EID: 84876123583     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2013.01.001     Document Type: Review

References (101)

1. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126:443-456.
2. Kendig J.W., Notter R.H., Cox C., et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991, 324:865-871.
3. Angus D.C., Linde-Zwirble W.T., Clermont G., et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 2001, 164:1154-1160.
4. Lemons J.A., Bauer C.R., Oh W., et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001, 107:e1.
5. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002, 110:285-291.
6. Allen J., Zwerdling R., Ehrenkranz R., et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003, 168:356-396.
7. Tucker J., McGuire W. Epidemiology of preterm birth. Br Med J (Clin Res Ed) 2004, 329:675-678.
8. Baraldi E., Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007, 357:1946-1955.
9. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2005. Natl Vital Stat Rep 2007, 56:1-103.
10. Wilson-Costello D., Friedman H., Minich N., et al. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics 2005, 115:997-1003.
11. Field D.J., Dorling J.S., Manktelow B.N., et al. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5. Br Med J (Clin Res Ed) 2008, 336:1221-1223.
12. Saigal S., Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008, 371:261-269.
13. Coalson J.J. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:179-184.
14. Berman W., Yabek S.M., Dillon T., et al. Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics 1982, 70:708-712.
15. Motoyama E.K., Fort M.D., Klesh K.W., et al. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1987, 136:50-57.
16. Abman S.H., Groothius J.R. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am 1994, 41:277-315.
17. Gerhardt T., Hehre D., Feller R., et al. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr 1987, 110:448-456.
18. Hislop A.A., Haworth S.G. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990, 9:152-161.
19. Margraf L.R., Tomashefski J.F., Bruce M.C., et al. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991, 143:391-400.
20. Van Lierde S., Cornelis A., Devlieger H., et al. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study. Biol Neonate 1991, 60:152-162.
21. Sward-Comunelli S.L., Mabry S.M., Truog W.E., et al. Airway muscle in preterm infants: changes during development. J Pediatr 1997, 130:570-576.
22. Husain A.N., Siddiqui N.H., Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998, 29:710-717.
23. Northway W.H. Bronchopulmonary dysplasia: thirty-three years later. Pediatr Pulmonol 2001, 23:5-7.
24. Balinotti J.E., Chakr V.C., Tiller C., et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 2010, 181:1093-1097.
25. Northway H.W., Moss R.B., Carlisle K.B., et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990, 323:1793-1799.
26. Northway W.H. Bronchopulmonary dysplasia-25 years later. Pediatrics 1992, 89:969-973.
27. Bhutani V.K., Abbasi S. Long-term pulmonary consequences in survivors with bronchopulmonary dysplasia. Clin Perinatol 1992, 19:649-671.
28. Weibel E.R. Morphometry of the Lung 1963, Academic Press, New York, [78-82].
29. Crapo J.D., Young S.L., Fram E.K., et al. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983, 128:S42-S46.
30. Albertine K.H. Anatomy of the lungs. Murray & Nadel's Textbook of Respiratory Medicine 2010, 3-25. WB Saunders/Elsevier, Philadelphia. 5th ed. R.J. Mason, V.C. Broaddus, T.R. Martin (Eds.).
31. Albertine K.H., Pysher T.J. Impaired lung growth after injury in premature lung. Fetal and Neonatal Physiology 2011, 1039-1047. Elsevier Sciences, NY. 4th ed. R.A. Polin, W.W. Fox, S. Abman (Eds.).
32. Albertine K.H. Aiding ill infants. Int Innov 2009, 33-35.
33. Escobedo M.B., Hilliard J.L., Smith F., et al. A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol 1982, 37:323-334.
34. Coalson J.J., Kuehl T.J., Escobedo M.B., et al. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol 1982, 37:335-350.
35. Coalson J.J., Winter V.T., Gerstmann D.R., et al. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992, 145:872-881.
36. deLemos R.A., Coalson J.J. The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol 1992, 19:521-539.
37. Coalson J.J., Winter V.T., Siler-Khodr T., et al. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999, 160:1333-1346.
38. Yoder B.A., Siler-Khodr T., Winter V.T., et al. High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. Am J Respir Crit Care Med 2000, 162:1867-1876.
39. McGreal E.P., Chakraborty M., Winter V.T., et al. Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation. Neonatology 2011, 100:130-138.
40. Pierce R.A., Albertine K.H., Starcher B.C., et al. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol Lung Cell Mol Physiol 1997, 272:L452-L460.
41. Albertine K.H., Jones G.P., Starcher B.C., et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 1999, 159:945-958.
42. MacRitchie A.N., Albertine K.H., Sun J., et al. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1011-L1020.
43. Bland R.D., Albertine K.H., Carlton D.P., et al. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 2000, 48:64-74.
44. Bland R.D., Ling C.Y., Albertine K.H., et al. Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2003, 285:L76-L85.
45. Bland R.D., Xu L., Ertsey R., et al. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1370-L1384.
46. Reyburn B., Li M., Metcalfe D.B., et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med 2008, 178:407-418.
47. Albertine K.H., Dahl M.J., Gonzales L.W., et al. Chronic lung disease in preterm lambs: effect of daily vitamin A treatment on alveolarization. Am J Physiol Lung Cell Mol Physiol 2010, 299:L59-L72.
48. Stocker J.T. Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 1986, 17:943-961.
49. Coalson J.J., Kuehl T.J., Prihoda T.J., et al. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon. Pediatr Res 1988, 24:357-366.
50. Burri P.H. Structural aspects of prenatal and postnatal development and growth of the lung. Lung Growth and Development 1997, 1-35. Marcel Dekker, Inc., NY. J.A. McDonald (Ed.).
51. Lindahl P., Karlsson L., Hellstrom M., et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 1997, 124:3943-3953.
52. Wendel D.P., Taylor D.G., Albertine K.H., et al. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol 2000, 23:320-326.
53. Burri P.H. Fetal and postnatal development of the lung. Annu Rev Physiol 1984, 46:617-628.
54. Schachtner S.K., Wang Y., Baldwin H.S. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol 2000, 22:157-165.
55. Maniscalco W.M., Watkins R.H., Pryhuber G.S., et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002, 282:L811-L823.
56. Brandt R.B., Mueller D.G., Schroeder J.R., et al. Serum vitamin A in premature and term neonates. J Pediatr 1978, 92:101-104.
57. Hustead V.A., Gutcher G.R., Anderson S.A., et al. Relationship of vitamin A (retinol) status to lung disease in the preterm infant. J Pediatr 1984, 105:610-615.
58. Shenai J.P., Chytil F., Stahlman M.T. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res 1985, 19:185-188.
59. Shenai J.P., Chytil F. Vitamin A storage in lungs during perinatal development in the rat. Biol Neonate 1990, 57:126-132.
60. Ambalavanan N., Tyson J.E., Kennedy K.A., et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005, 115:e249-e254.
61. Tyson J.E., Ehrenkranz R.A., Stoll B.J., et al. Vitamin (Vit.) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14-center randomized trial. Pediatr Res 1998, 43:199A.
62. Tyson J.E., Wright L.L., Oh W., et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999, 340:1962-1968.
63. Pierce R.A., Joyce B., Officer S., et al. Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons. Pediatr Res 2007, 61:703-709.
64. Coalson J.J., Winter V., deLemos R.A. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995, 152:640-646.
65. Abman S.H., Wolfe R.R., Accurso F.J., et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985, 75:80-84.
66. Bush A., Busst C.M., Knight W.B., et al. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990, 65:739-745.
67. Bhat R., Salas A.A., Foster C., et al. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012, 129:e682-e689.
68. Tomashefski J.F., Oppermann H.C., Vawter G.F., et al. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984, 2:469-487.
69. Coalson J.J. Pathology of chronic lung disease of early infancy. Chronic Lung Disease in Early Infancy 2000, 85-124. Marcel Dekker, Inc., NY. R.D. Bland, J.J. Coalson (Eds.).
70. Afshar S., Gibson L.L., Yuhanna I.S., et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2003, 284:L749-L758.
71. Shaul P.W., Afshar S., Gibson L.L., et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol 2002, 283:L1192-L1199.
72. Bland R.D., Albertine K.H., Carlton D.P., et al. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 2005, 172:899-906.
73. Thomae K.R., Nakayama D.K., Billiar T.R., et al. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 1995, 59:337-343.
74. Hamad A.M., Johnson S.R., Knox A.J. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 1999, 277:L910-L918.
75. Rudic R.D., Shesely E.G., Maeda N., et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998, 101:731-736.
76. Guo J.P., Panday M.M., Consigny P.M., et al. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol 1995, 269:H1122-H1131.
77. Seki J., Nishio M., Kato Y., et al. FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Atherosclerosis 1995, 117:97-106.
78. Lee J.S., Adrie C., Jacob H.J., et al. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res 1996, 78:337-342.
79. Banks B.A., Seri I., Ischiropoulos H., et al. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999, 103:610-618.
80. McCurnin D.C., Pierce R.A., Chang L.Y., et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2005, 288:L450-L459.
81. Howlett C.E., Hutchison J.S., Veinot J.P., et al. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. Am J Physiol 1999, 277:L596-L605.
82. Wingrove J.A., O'Farrell P.H. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell 1999, 98:105-114.
83. Edwards Y.S., Sutherland L.M., Murray A.W. NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1236-L1242.
84. Fawke J., Lum S., Kirkby J., et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010, 182:237-245.
85. Coalson J.J. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003, 8:73-81.
86. Jakupaj M., Martin R.J., Dreshaj I.A., et al. Role of endogenous NO in modulating airway contraction mediated by muscarinic receptors during development. Am J Physiol Lung Cell Mol Physiol 1997, 273:L531-L536.
87. Potter C.F., Dreshaj I.A., Haxhiu M.A., et al. Effect of exogenous and endogenous nitric oxide on the airway and tissue components of lung resistance in the newborn piglet. Pediatr Res 1997, 41:886-891.
88. Van Marter L.J., Allred E.N., Pagano M., et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000, 105:1194-1201.
89. Jobe A.H., Kramer B.W., Moss T.J., et al. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002, 52:387-392.
90. Thomson M.A., Yoder B.A., Winter V.T., et al. Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. Am J Respir Crit Care Med 2004, 169:1054-1062.
91. Joss-Moore L.A., Albertine K.H., Lane R.H. Epigenetics and the developmental origins of lung disease. Mol Genet Metab 2011, 104:61-66.
92. Luger K., Mader A.W., Richmond R.K., et al. Crystal structure of the nucleosome core particle at 2.8A resolution. Nature 1997, 389:251-260.
93. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
94. Roth D.M., Balch W.E. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol 2011, 23:126-134.
95. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012, 13:484-492.
96. Sato F., Tsuchiya S., Meltzer S.J., et al. MicroRNAs and epigenetics. FEBS J 2011, 278:1598-1609.
97. Lallemand A.V., Ruocco S.M., Joly P.M., et al. In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development. Int J Dev Biol 1995, 39:529-537.
98. Chetty A., Andersson S., Lassus P., et al. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1 R) expression in human lung in RDS and BPD. Pediatr Pulmonol 2004, 37:128-136.
99. Fu Q., Yu X., Callaway C.W., et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J 2009, 23:2438-2449.
100. Ke X., Lei Q., James S.J., et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics 2006, 25:16-28.
101. Morbidelli L., Chang C.H., Douglas J.G., et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996, 270:H411-H415.